{"&cites=3788006772024382059&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","url":"https://ard.bmj.com/content/73/3/492.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2014,"numCitations":2331,"pdf":"https://ard.bmj.com/content/annrheumdis/73/3/492.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15630718529220191090&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ciNJ7q9369gJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15630718529220191090&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com","p":1,"exp":1596893544419},{"title":"The PREMIER study: a multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.21519","authors":["FC Breedveld","FC Breedveld MH Weisman…"],"year":2006,"numCitations":2133,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.21519","citationUrl":"http://scholar.google.com/scholar?cites=12894171158113881425&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:UQ13IFpM8bIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12894171158113881425&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","url":"https://ard.bmj.com/content/69/6/964.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2010,"numCitations":2113,"pdf":"https://ard.bmj.com/content/annrheumdis/69/6/964.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18242945375836507497&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:aQ2X_yn2K_0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18242945375836507497&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.39480","authors":["JA Singh","JA Singh KG Saag","JA Singh KG Saag SL Bridges Jr","JA Singh KG Saag SL Bridges Jr EA Akl…"],"year":2016,"numCitations":2044,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39480","citationUrl":"http://scholar.google.com/scholar?cites=6477801428873898453&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:1emLJRTG5VkJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6477801428873898453&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.21405","authors":["YPM Goekoop‐Ruiterman…"],"year":2005,"numCitations":1810,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.21405","citationUrl":"http://scholar.google.com/scholar?cites=8728464579464526668&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:TPuPJUq8IXkJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8728464579464526668&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.23721","authors":["KG Saag","KG Saag GG Teng","KG Saag GG Teng NM Patkar…"],"year":2008,"numCitations":1781,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.23721","citationUrl":"http://scholar.google.com/scholar?cites=17112596124214357976&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:2O-FMIInfO0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17112596124214357976&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","url":"https://ard.bmj.com/content/76/6/960.abstract","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé J Bijlsma…"],"year":2017,"numCitations":1810,"pdf":"http://eprints.whiterose.ac.uk/116927/1/annrheumdis-2016-210715.pdf","citationUrl":"http://scholar.google.com/scholar?cites=532213958404936786&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:UhQ7f8bNYgcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=532213958404936786&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"TNF‐mediated inflammatory disease","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/path.2287","authors":["JR Bradley"],"year":2008,"numCitations":1759,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.2287","citationUrl":"http://scholar.google.com/scholar?cites=10827936573528950980&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:xEin2_GORJYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10827936573528950980&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","url":"https://www.sciencedirect.com/science/article/pii/S0163725807002069","authors":["D Tracey","D Tracey L Klareskog","D Tracey L Klareskog EH Sasso","D Tracey L Klareskog EH Sasso JG Salfeld…"],"year":2008,"numCitations":1650,"citationUrl":"http://scholar.google.com/scholar?cites=848955606561904576&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:wNcyT6AYyAsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=848955606561904576&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.20568","authors":["EW St. Clair","EW St. Clair DMFM Van Der Heijde…"],"year":2004,"numCitations":1425,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.20568","citationUrl":"http://scholar.google.com/scholar?cites=10013342158858176201&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:yUYv-aOJ9ooJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10013342158858176201&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"}]}